SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
BTX BioTime
An SI Board Since July 2014
Posts SubjectMarks Bans Symbol
69 5 0 BTX
Emcee:  Savant Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
44BioTime Achieves Patient Recruitment Milestone in Renevia Pivotal Trial Dec 14,Savant-12/14/2016
43BioTime to Present at Global Bioproduction Summit Dec 12, 2016 07:00:00 (ET) CSavant-12/12/2016
42Positive Early Data From BioTime's Renevia Pivotal Trial Presented at IFATS Savant-11/18/2016
41AST escalating cell count/ 1st patient w/20 mln cell count, also 2nd w/10 mln coSavant-11/10/2016
40BioTime, Inc. (NYSE MKT:BTX), a clinical stage biotechnology company with a focuSavant-11/1/2016
39First Patient Cohort Data From BioTime's -2- Oct 20, 2016 06:30:00 (ET) - Savant-10/20/2016
38First dosing in SCiSTAR study of an AIS-B patient, characterized as having complSavant-9/27/2016
37BioTime, Inc. (NYSE MKT:BTX), a clinical stage regenerative medicine company witSavant-9/23/2016
36RT..AST great news for spinal cord injury patients/Efficacy in 3 months @ higherSavant-9/14/2016
35FREMONT, Calif., Sept. 12, 2016 /PRNewswire/ -- Asterias Biotherapeutics, Inc. (Savant-9/12/2016
34Asterias Biotherapeutics Announces Interim Efficacy Data from SCiStar Clinical TSavant-9/7/2016
338/15 BioTime, Inc. (NYSE MKT:BTX) today announced the issuance of 31 new patentSavant-8/15/2016
32-- Therapeutic Candidates Continue Clinical Progress -- Deconsolidation SiSavant-8/10/2016
31ALAMEDA, Calif.--(BUSINESS WIRE)--July 05, 2016-- BioTime, Inc. (NYSE MKT: BTX)Savant-7/13/2016
30Prior CC//From Seeking Alpha: BioTime (BTX) Investor Update Call (TranscriptSavant-4/5/2016
29RT.. FREMONT, Calif., Feb. 29, 2016 /PRNewswire/ -- Asterias BiotherapeuticsSavant-2/29/2016
28BioTime, Inc. (NYSE MKT:BTX), a clinical-stage regenerative medicine companySavant-2/24/2016
27FREMONT, Calif. & ALAMEDA, Calif.--(BUSINESS WIRE)--February 16, 2016-- Savant-2/17/2016
26BTX / OCX --BioTime Completes Distribution of Approximately 4.75 Million Shares Savant-1/4/2016
25 BioTime Licenses Beckman Research Institute of City of Hope to ManufSavant-5/5/2015
24 BioTime's Clinical Grade Stem Cells From Subsidiary ES Cell InteSavant-5/5/2015
23 Cell Cure Neurosciences Announces Preclinical Efficacy Data DemonstrSavant15/4/2015
22BioTime and its OncoCyte subsidiary announce initial data from a large, prospectseminole14/21/2015
21Worth following up on....IMOSavant-4/16/2015
20So some how, shares of AST and BTXWS showed up in my retirement account. Up to nseminole-4/16/2015
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News